These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10475110)

  • 1. Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm).
    Gicheru MM; Otsyula M; Spearman P; Graham BS; Miller CJ; Robinson HL; Haigwood NL; Montefiori DC
    J Med Primatol; 1999 Jun; 28(3):97-104. PubMed ID: 10475110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.
    Amos JD; Himes JE; Armand L; Gurley TC; Martinez DR; Colvin L; Beck K; Overman RG; Liao HX; Moody MA; Permar SR
    J Virol; 2015 Sep; 89(18):9485-98. PubMed ID: 26157116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
    Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock.
    Lopker M; Easlick J; Sterrett S; Decker JM; Barbian H; Learn G; Keele BF; Robinson JE; Li H; Hahn BH; Shaw GM; Bar KJ
    J Virol; 2013 May; 87(10):5477-92. PubMed ID: 23468494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys.
    Norley SG; Kraus G; Ennen J; Bonilla J; König H; Kurth R
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9067-71. PubMed ID: 2247482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys.
    Yeh WW; Rahman I; Hraber P; Coffey RT; Nevidomskyte D; Giri A; Asmal M; Miljkovic S; Daniels M; Whitney JB; Keele BF; Hahn BH; Korber BT; Shaw GM; Seaman MS; Letvin NL
    J Virol; 2010 Jun; 84(12):6018-32. PubMed ID: 20357097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.
    Rybarczyk BJ; Montefiori D; Johnson PR; West A; Johnston RE; Swanstrom R
    J Virol; 2004 Apr; 78(7):3561-71. PubMed ID: 15016879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys.
    Wilks AB; Perry JR; Ehlinger EP; Zahn RC; White R; Gauduin MC; Carville A; Seaman MS; Schmitz JE; Permar SR
    J Virol; 2011 Sep; 85(18):9517-26. PubMed ID: 21734053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization of rhesus macaques against SIV infection and disease.
    Gardner M; Rosenthal A; Jennings M; Yee J; Antipa L; Robinson E
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):843-54. PubMed ID: 7546912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
    König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
    J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of Heterologous Simian Immunodeficiency Virus SIV
    Singh S; Ramírez-Salazar EG; Doueiri R; Valentin A; Rosati M; Hu X; Keele BF; Shen X; Tomaras GD; Ferrari G; LaBranche C; Montefiori DC; Das J; Alter G; Trinh HV; Hamlin C; Rao M; Dayton F; Bear J; Chowdhury B; Alicea C; Lifson JD; Broderick KE; Sardesai NY; Sivananthan SJ; Fox CB; Reed SG; Venzon DJ; Hirsch VM; Pavlakis GN; Felber BK
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
    Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
    Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Envelope variable region 4 is the first target of neutralizing antibodies in early simian immunodeficiency virus mac251 infection of rhesus monkeys.
    Yeh WW; Brassard LM; Miller CA; Basavapathruni A; Zhang J; Rao SS; Nabel GJ; Mascola JR; Letvin NL; Seaman MS
    J Virol; 2012 Jul; 86(13):7052-9. PubMed ID: 22532675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential evolution and escape from neutralization of simian immunodeficiency virus SIVsmE660 clones in rhesus macaques.
    Wu F; Ourmanov I; Kuwata T; Goeken R; Brown CR; Buckler-White A; Iyengar R; Plishka R; Aoki ST; Hirsch VM
    J Virol; 2012 Aug; 86(16):8835-47. PubMed ID: 22696650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus.
    Zhang R; Martinez DR; Nguyen QN; Pollara J; Arifin T; Stolarchuk C; Foulger A; Amos JD; Parks R; Himes JE; Wang M; Edwards RW; Trama AM; Vandergrift N; Colvin L; Dewar K; Juretic N; Wasserscheid J; Ferrari G; Liao HX; Permar SR
    Nat Commun; 2016 Jul; 7():12131. PubMed ID: 27381634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.
    Broussard SR; Staprans SI; White R; Whitehead EM; Feinberg MB; Allan JS
    J Virol; 2001 Mar; 75(5):2262-75. PubMed ID: 11160730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses.
    Asmal M; Sun Y; Lane S; Yeh W; Schmidt SD; Mascola JR; Letvin NL
    J Virol; 2011 Jun; 85(11):5465-75. PubMed ID: 21450829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of macaque monkeys with simian immunodeficiency virus from African green monkeys: virulence and activation of latent infection.
    Gravell M; London WT; Hamilton RS; Stone G; Monzon M
    J Med Primatol; 1989; 18(3-4):247-54. PubMed ID: 2547960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host.
    Gaufin T; Pattison M; Gautam R; Stoulig C; Dufour J; MacFarland J; Mandell D; Tatum C; Marx MH; Ribeiro RM; Montefiori D; Apetrei C; Pandrea I
    J Virol; 2009 Oct; 83(20):10347-57. PubMed ID: 19656874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.